{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:01:51Z","timestamp":1781103711432,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,9]]},"DOI":"10.7759\/cureus.26699","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T20:54:16Z","timestamp":1657400056000},"source":"Crossref","is-referenced-by-count":6,"title":["Association of Serum Hepcidin With Preeclampsia: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Arkapal","family":"Bandyopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Ahamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Palepu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tandra","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai B","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005, 365:785-99. 10.1016\/S0140-6736(05)17987-2","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2018.10.011","article-title":"Preeclampsia: disease biology and burden, its management strategies with reference to India","volume":"15","author":"Malik A","year":"2019","unstructured":"Malik A, Jee B, Gupta SK. Preeclampsia: disease biology and burden, its management strategies with reference to India. Pregnancy Hypertens. 2019, 15:23-31. 10.1016\/j.preghy.2018.10.011","journal-title":"Pregnancy Hypertens"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2381","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton GJ","year":"2019","unstructured":"Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019, 366:l2381. 10.1136\/bmj.l2381","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.07.040","article-title":"Maternal infection and risk of preeclampsia: systematic review and metaanalysis","volume":"198","author":"Conde-Agudelo A","year":"2008","unstructured":"Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2008, 198:7-22. 10.1016\/j.ajog.2007.07.040","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/nu6083062","article-title":"Hepcidin and iron homeostasis during pregnancy","volume":"6","author":"Koenig MD","year":"2014","unstructured":"Koenig MD, Tussing-Humphreys L, Day J, Cadwell B, Nemeth E. Hepcidin and iron homeostasis during pregnancy. Nutrients. 2014, 6:3062-83. 10.3390\/nu6083062","journal-title":"Nutrients"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3945\/an.116.013961","article-title":"Regulation of the iron homeostatic hormone hepcidin","volume":"8","author":"Sangkhae V","year":"2017","unstructured":"Sangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin. Adv Nutr. 2017, 8:126-36. 10.3945\/an.116.013961","journal-title":"Adv Nutr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003150","article-title":"Hepcidin: a promising therapeutic target for iron disorders: a systematic review","volume":"95","author":"Liu J","year":"2016","unstructured":"Liu J, Sun B, Yin H, Liu S. Hepcidin: a promising therapeutic target for iron disorders: a systematic review. Medicine (Baltimore). 2016, 95:e3150. 10.1097\/MD.0000000000003150","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2012-0576","article-title":"The iron regulatory hormone hepcidin is decreased in pregnancy: a prospective longitudinal study","volume":"51","author":"van Santen S","year":"2013","unstructured":"van Santen S, Kroot JJ, Zijderveld G, Wiegerinck ET, Spaanderman ME, Swinkels DW. The iron regulatory hormone hepcidin is decreased in pregnancy: a prospective longitudinal study. Clin Chem Lab Med. 2013, 51:1395-401. 10.1515\/cclm-2012-0576","journal-title":"Clin Chem Lab Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1689561","article-title":"Diagnostic ability of hepcidin in predicting fetal outcome in preeclampsia","volume":"34","author":"Nila SG","year":"2021","unstructured":"Nila SG, Bobby Z, Dorairajan G, Jacob SE. Diagnostic ability of hepcidin in predicting fetal outcome in preeclampsia. J Matern Fetal Neonatal Med. 2021, 34:3678-83. 10.1080\/14767058.2019.1689561","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009, 151:264-9, W64. 10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"key":"ref11","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2020). Accessed. October 05, 2020: https:\/\/www.ohri.ca\/\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2010.290","article-title":"Hepcidin concentrations and iron homeostasis in preeclampsia","volume":"48","author":"Toldi G","year":"2010","unstructured":"Toldi G, Stenczer B, Molvarec A, Tak\u00e1ts Z, Beko G, Rig\u00f3 J Jr, V\u00e1s\u00e1rhelyi B. Hepcidin concentrations and iron homeostasis in preeclampsia. Clin Chem Lab Med. 2010, 48:1423-6. 10.1515\/CCLM.2010.290","journal-title":"Clin Chem Lab Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/10641955.2014.988350","article-title":"Is the level of maternal serum prohepcidin associated with preeclampsia?","volume":"34","author":"Duvan CI","year":"2015","unstructured":"Duvan CI, Simavli S, Keskin EA, Onaran Y, Turhan NO, Koca C. Is the level of maternal serum prohepcidin associated with preeclampsia?. Hypertens Pregnancy. 2015, 34:145-52. 10.3109\/10641955.2014.988350","journal-title":"Hypertens Pregnancy"},{"key":"ref14","article-title":"Evaluation of the changes in iron homeostasis and hepcidin concentration in preeclamptic patients","volume":"5","author":"Muhsin NA","year":"2016","unstructured":"Muhsin NA, Al-Mudalal SS, Hameed BM. Evaluation of the changes in iron homeostasis and hepcidin concentration in preeclamptic patients. Iraqi J Hemat. 2016, 5:32-40.","journal-title":"Iraqi J Hemat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2017.12.008","article-title":"Maternal serum levels and placental expression of hepcidin in preeclampsia","volume":"11","author":"Cardaropoli S","year":"2018","unstructured":"Cardaropoli S, Todros T, Nuzzo AM, Rolfo A. Maternal serum levels and placental expression of hepcidin in preeclampsia. Pregnancy Hypertens. 2018, 11:47-53. 10.1016\/j.preghy.2017.12.008","journal-title":"Pregnancy Hypertens"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2018.03.005","article-title":"Increased serum iron in preeclamptic women is likely due to low hepcidin levels","volume":"53","author":"Brunacci F","year":"2018","unstructured":"Brunacci F, Rocha VS, De Carli E, Esp\u00f3sito BP, Ruano R, Colli C. Increased serum iron in preeclamptic women is likely due to low hepcidin levels. Nutr Res. 2018, 53:32-9. 10.1016\/j.nutres.2018.03.005","journal-title":"Nutr Res"},{"key":"ref17","article-title":"Correlative study of serum hepcidin levels and serum iron reserve parameters in pre-eclampsia and HELLP syndrome","volume":"55","author":"Kumar T","year":"2018","unstructured":"Kumar T, Zahra K, Dey T, Singh A, Pandey U, Mishra SP. Correlative study of serum hepcidin levels and serum iron reserve parameters in pre-eclampsia and HELLP syndrome. Indian J Biochem Biophys. 2018, 55:420-23.","journal-title":"Indian J Biochem Biophys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1730322","article-title":"Increased hepcidin levels in preeclampsia: a protective mechanism against iron overload mediated oxidative stress?","volume":"35","author":"Shaji Geetha N","year":"2022","unstructured":"Shaji Geetha N, Bobby Z, Dorairajan G, Jacob SE. Increased hepcidin levels in preeclampsia: a protective mechanism against iron overload mediated oxidative stress?. J Matern Fetal Neonatal Med. 2022, 35:636-41. 10.1080\/14767058.2020.1730322","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1224577","article-title":"Hepcidin and the iron-infection axis","volume":"338","author":"Drakesmith H","year":"2012","unstructured":"Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science. 2012, 338:768-72. 10.1126\/science.1224577","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2012.00966.x","article-title":"Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia?","volume":"17","author":"Franceschi F","year":"2012","unstructured":"Franceschi F, Di Simone N, D'Ippolito S, et al.. Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia?. Helicobacter. 2012, 17:426-34. 10.1111\/j.1523-5378.2012.00966.x","journal-title":"Helicobacter"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.117.155812","article-title":"Iron homeostasis during pregnancy","volume":"106","author":"Fisher AL","year":"2017","unstructured":"Fisher AL, Nemeth E. Iron homeostasis during pregnancy. Am J Clin Nutr. 2017, 106:1567S-74S. 10.3945\/ajcn.117.155812","journal-title":"Am J Clin Nutr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.538","article-title":"Hepcidin modulation in human diseases: from research to clinic","volume":"15","author":"Piperno A","year":"2009","unstructured":"Piperno A, Mariani R, Trombini P, Girelli D. Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol. 2009, 15:538-51. 10.3748\/wjg.15.538","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1039\/c4cc07996e","article-title":"Ferritin light-chain subunits: key elements for the electron transfer across the protein cage","volume":"50","author":"Carmona U","year":"2014","unstructured":"Carmona U, Li L, Zhang L, Knez M. Ferritin light-chain subunits: key elements for the electron transfer across the protein cage. Chem Commun (Camb). 2014, 50:15358-61. 10.1039\/c4cc07996e","journal-title":"Chem Commun (Camb)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.02.019","article-title":"Iron-mediated oxidative stress plays an essential role in ferritin-induced cell death","volume":"48","author":"Bresgen N","year":"2010","unstructured":"Bresgen N, Jaksch H, Lacher H, Ohlenschl\u00e4ger I, Uchida K, Eckl PM. Iron-mediated oxidative stress plays an essential role in ferritin-induced cell death. Free Radic Biol Med. 2010, 48:1347-57. 10.1016\/j.freeradbiomed.2010.02.019","journal-title":"Free Radic Biol Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.12.034","article-title":"A red carpet for iron metabolism","volume":"168","author":"Muckenthaler MU","year":"2017","unstructured":"Muckenthaler MU, Rivella S, Hentze MW, Galy B. A red carpet for iron metabolism. Cell. 2017, 168:344-61. 10.1016\/j.cell.2016.12.034","journal-title":"Cell"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39426-5","article-title":"Trophoblast-specific expression of Hif-1\u03b1 results in preeclampsia-like symptoms and fetal growth restriction","volume":"9","author":"Albers RE","year":"2019","unstructured":"Albers RE, Kaufman MR, Natale BV, et al.. Trophoblast-specific expression of Hif-1\u03b1 results in preeclampsia-like symptoms and fetal growth restriction. Sci Rep. 2019, 9:2742. 10.1038\/s41598-019-39426-5","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.3.969","article-title":"Iron regulates nitric oxide synthase activity by controlling nuclear transcription","volume":"180","author":"Weiss G","year":"1994","unstructured":"Weiss G, Werner-Felmayer G, Werner ER, Gr\u00fcnewald K, Wachter H, Hentze MW. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med. 1994, 180:969-76. 10.1084\/jem.180.3.969","journal-title":"J Exp Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/103153-association-of-serum-hepcidin-with-preeclampsia-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:09Z","timestamp":1707507549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/103153-association-of-serum-hepcidin-with-preeclampsia-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.26699","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,9]]}}}